Posts Tagged ‘Wall Street Journal’
JULY 29, 2009, 12:18 P.M. ETÂ Â
WASHINGTON — The Centers for Disease Control and Prevention said Wednesday pregnant women suspected of having the flu should be promptly treated with antiviral medications.
The CDC, in a study set to be published in the medical journal Lancet, said pregnant women are more severely impacted by the H1N1 virus. CDC said pregnant women had higher rates of hospitalization and a greater risk of death compared to the general population.
The study looked at the impact of H1N1 flu on pregnant women from mid-April, when the new virus was first discovered, to June 16. Of 45 U.S. deaths from the H1N1 flu, six were in pregnant women, which represented 13% of deaths at the time. CDC said of the 34 cases of pandemic H1N1 in pregnant women were reported to the agency from April 15 to May 18, 11 women, or 32% were admitted to the hospital.
The CDC has said more than one million Americans have likely been sickened by the H1N1 flu and more than 300 people have died as of July 24.
The lead author of the study, Denise Jamieson, said doctors who treat pregnant women shouldn’t delay in starting antiviral treatment with Tamiflu, made by Roche Holding AG, or GlaxoSmithKline PLC’s Relenza.
“Some clinicians hesitate treating pregnant women with antiviral medications because of concerns for the developing fetus, but this is the wrong approach,” she said.
All of the pregnant women who died from H1N1 complications flu were healthy prior to infection of H1N1. They subsequently developed viral pneumonia, and later died. CDC said they did not receive antivirals soon enough to benefit their treatment. It’s recommended that antiviral treatment be started within 48 hours after symptoms begin.
CDC’s Advisory Committee on Immunization Practices meets later Wednesday to discuss which groups should be vaccinated if government officials decide to move forward with an H1N1 influenza vaccination campaign. Pregnant women, school-age children and health-care workers are expected to be at the top of the list. The earliest an H1N1 vaccine would be available would be mid-October.
Most companies making the vaccines for the U.S. market, including Sanofi Aventis, Novartis AG, GlaxoSmithKline PLC and CSL Ltd, have said the viruses used to make the active ingredient are producing yields of just 30% of what’s typically seen with seasonal vaccines.
Write to Jennifer Corbett Dooren at email@example.com
July 18, 2009
U.S. health officials are preparing intensively to combat an anticipated wave of outbreaks of the new H1N1 flu when children return to school and the pace of cases picks up.
Anne Schuchat, chief of immunization and respiratory diseases at the U.S. Centers for Disease Control and Prevention, said Friday that the agency expects an increase in cases before the normal start of the flu season in mid-autumn, because children are likely to spread it to one another once they go back to school. Infectious diseases normally spread readily among children, and this virus has hit children and young adults harder than the elderly, who normally suffer the heaviest toll from flu.
“We’ve seen it in camps and military units,” Dr. Schuchat said. “I’m expecting when school reopens and kids are all back together, in some communities at least we may see an increase.”
The number of confirmed U.S. infections is now 40,617, with 263 deaths, the CDC said Friday. But the agency believes that more than one million people have been infected and weren’t tested for the virus or didn’t visit a doctor. The disease has become so widespread that the agency will probably suspend tallying individual case counts within the next few weeks and focus instead on tracking clusters, severe cases, deaths and other unusual events — a more traditional approach to tracking diseases, Dr. Schuchat said.
The CDC would be following the WHO, which said on Thursday that it is abandoning individual case counts.
Most of those who have the new flu get only mildly ill for a few days and don’t need treatment. But officials are concerned about the virus because it is new and could easily mutate and become more virulent as it spreads through the population. Argentina declared a nationwide animal-health emergency Friday after finding the virus possibly jumped from humans to two pig herds, a development that flu experts say could potentially spur mutations. The country’s death toll from the virus stands at 137.
Global officials are also concerned because the new H1N1 virus has caused severe illness in some children and young people. Some recently published studies suggest it can cause more severe illness than seasonal flu. Deaths from flu are normally rare among children and young adults, who account for the bulk of the U.S. deaths from the pandemic strain. Nor is it clear why the virus is striking pregnant women, as well as people with asthma, diabetes and other conditions hard.
To combat the virus, federal officials are preparing to mount a massive immunization campaign, and are also urging communities, businesses and individuals to make contingency plans for possible school closures, multiple employee absences for illness, surges of patients in hospitals and other effects of potentially widespread outbreaks.
Clinical trials are expected to begin later this month to test whether a vaccine developed to combat the virus is safe and effective, and the CDC is working with state and local public-health authorities to figure out how to get as many as 600 million doses, or two for every U.S. resident, into people’s arms. Results of the trials aren’t expected until early October, but officials say they expect to have the first 100 million doses of vaccine ready by mid-October.
The WHO and some vaccine manufacturers reported this week that the vaccine was proving difficult to manufacture because the viruses used to make the shots are yielding only 25% to 50% of the active ingredient they normally get for flu vaccines.
But Dr. Schuchat said that wasn’t affecting the U.S. government’s plans. “We haven’t heard news that has changed our expectations for vaccine availability in the fall,” she said. “Based on what has been described to us so far, it’s within the range of our planning assumptions, but that doesn’t mean we won’t have more surprises.”
By Shirley S. Wang
July 16, 2009
The virus is spreading with â€œunprecedented speedâ€, wrote the WHO. â€œAt this point, further spread of the pandemic, within affected countries and to new countries, is considered inevitable.â€
But countries need to continue to closely monitor â€œunusual eventsâ€ like clusters of severe virus infections or unusual patterns of these serious cases. These signals might come from noticing an increase in the number of people staying home from work or school, or by an increase in emergency room visits.